#trends today for 'generic drug' 'easing mortgage' & 'homes sales'
Click/Tap below:
www.newsmason.com?query=%22gen...
www.newsmason.com?query=%22eas...
www.newsmason.com?query=%22hom...
#genericdrug #easingmortgage #homessales
Columns: Health Policy Portal Certification Marks for Supporting Generic Drug Quality Lars Lindgren1, Aaron S. Kesselheim2 and S. Sean Tu3 1University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States; 2Program On Regulation, Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA and 3West Virginia University College of Law, Morgantown, WV Abstract Certification marks are a type of trademark used to show that a product or service meets specific standards or qualities set by an independent organization (not by the manufacturer or seller). Certification marks could enhance the quality perception and oversight of generic drugs. Despite the FDA’s rigorous regulatory framework, skepticism about generic drug quality persists among patients and prescribers, partly due to the FDA’s limited ability to inspect manufacturing facilities. Independent certification marks— similar to USDA Organic or Energy Star labels— could help communicate drug quality information more effectively to consumers, incentivize manufacturers to exceed baseline standards, and bolster trust in generics. Such a system could operate without legislative changes and offer a cost-effective supplement to existing FDA inspections, particularly given the challenges posed by an increasingly globalized drug supply chain and current FDA resource constraints. Keywords: generic drug; FDA
Now on FirstView: "Certification Marks for Supporting Generic Drug Quality" by Lars Lindgren,
@akesselheim.bsky.social, and S. Sean Tu. Generic certification marks would use the private market to supplement regulatory oversight.
#FDA #GenericDrug #GenericDrugs
www.cambridge.org/core/journal...
The Oregon Prescription Drug Affordability Board (PDAB) is meeting right now! They are discussing:
💊 How they'll report on #genericdrug prices
📝 Data collection from stakeholders—pharmaceutical companies, providers, #patients, and more
💰 Which drugs may be #unaffordable
#OCAP #ORpol
Highly recommend @katherineeban.bsky.social’s “Bottle of Lies: The Inside Story of the #GenericDrug Boom”. I haven’t been able to put it down. Seriously, such an important read. Especially if you take ANY medication.
#InvestigativeJournalism #Pharmaceuticals #Fraud #Health #FDA #ConsumerBeware
Posted a talk on slideshare that I gave a few years back on the #patent and #FDA aspects of #genericdrug approvals: www.slideshare.net/SteveZweig/generic-drug-...
